+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The influence of autologous tumor on tumor infiltrating lymphocytes til from renal cell carcinoma rcc on functional activity and phenotype



The influence of autologous tumor on tumor infiltrating lymphocytes til from renal cell carcinoma rcc on functional activity and phenotype



Proceedings of the American Association for Cancer Research Annual Meeting 30: 362




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 033843097

Download citation: RISBibTeXText


Related references

Human accessory cells activate fresh, autologous normal renal T-lymphocytes but not tumor infiltrating T-lymphocytes to lyse autologous tumor cells in a primary cytotoxic T-lymphocyte assay in renal-cell carcinoma. Journal of Urology 163(4 Suppl ): 115, 2000

Human accessory cells activate fresh, normal, tumor-distant T lymphocytes but not tumor-infiltrating T lymphocytes to lyse autologous tumor cells in a primary cytotoxic T lymphocyte assay in renal cell carcinoma. European Urology 40(4): 427-433, 2001

Autologous tumor-specific cytotoxicity of tumor-infiltrating lymphocytes derived from human renal cell carcinoma. Journal of ImmunoTherapy 10(5): 347-354, 1991

Mrna expression in tumor infiltrating lymphocytes til from renal cell carcinoma rcc and its correlation to functional activity. Journal of Urology 147(4 Suppl.): 412A, 1992

In vitro sensitivity testing of human renal cell carcinoma rcc with autologous and non autologous cytotoxic tumor infiltrating lymphocytes ctil. Journal of Urology 143(4 Suppl.): 384A, 1990

Tumor infiltrating lymphocytes from renal cell carcinoma possess functional cytotoxic activity transduced by the cd3 tcr complex. Proceedings of the American Association for Cancer Research Annual Meeting 32: 248, 1991

Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. Journal of Immunology 151(8): 4209-4220, 1993

Selective lysis of autologous tumor cells by recurrent cd tumor-infiltrating lymphocytes from renal carcinoma. Journal of Immunology 154: 32-40, 1995

Tumor specific cytotoxic T lymphocytes derived from tumor infiltrating lymphocytes and peripheral blood lymphocytes by in vitro sensitization with gene modified autologous tumor in breast carcinoma. Journal of Cellular Biochemistry Suppl. 0(18D): 253, 1994

Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma. Journal of Immunology 154(8): 3932-3940, 1995

Cytotoxic t cell ctl distribution and function against autologous tumors evaluation by cloned tumor infiltrating lymphocytes til from renal cell carcinoma. Journal of Urology 147(4 Suppl.): 458A, 1992

Recombinant interleukin-2-expanded tumor infiltrating lymphocytes from human renal cell cancer do not exhibit autologous tumor cell-specific cytotoxicity. Urologia Internationalis 47(Suppl. 1): 83-85, 1991

The influence of interleukin 4 on tumor infiltrating lymphocytes til from renal cell carcinoma. Journal of Urology 143(4 Suppl.): 309A, 1990

The influence of interleukin 4 on tumor infiltrating lymphocytes from renal cell carcinoma. Proceedings of the American Association for Cancer Research Annual Meeting 31: 239, 1990

Identification of colon-tumor-associated antigens by T-cell lines derived from tumor-infiltrating lymphocytes and peripheral-blood lymphocytes from patients immunized with an autologous tumor-cell/bacillus Calmette-Guérin vaccine. International Journal of Cancer 54(5): 734-740, 1993